Presenter will be Ambaw Bellete, President, Photocure Inc. and Head, US Cancer Commercial Operations. The slides presented will be available on Photocure’s website (www.photocure.com) in the investor relations section.
Erik Dahl, Chief Financial Officer
Tel: +47 450 55 000
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure.com, www.hexvix.com, www.cysview.com.